The Center for Thyroid Radiofrequency Ablation has an exciting update. Our manuscript to Video Endocrinology was recently accepted demonstrating the use of Radiofrequency Ablation (RFA) for the treatment of recurrent metastatic papillary thyroid carcinoma to a lymph node. Click the link below to review the results and watch the procedure in action. This cutting-edge non-surgical treatment is offered at our Provo, Lehi, and Millcreek offices. RFA can be used for large benign nodules, autonomously functioning thyroid nodules, and in select cases of primary hyperparathyroidism or thyroid cancer. The procedure is performed as an outpatient, in the office, with local anesthesia. No hospitalization is required and no scar. See the details below.
- Recurrent Papillary Thyroid Carcinoma of Central Compartment Node Treated With Radiofrequency Ablation
- Radiofrequency Ablation Is a Thyroid Sparing Treatment Option for Primary Hyperparathyroidism Caused by an Intrathyroidal Parathyroid Adenoma
- Radiofrequency Ablation Performed By Endocrinologists Is A Viable Treatment Option For Recurrent Thyroid Cancer In The Outpatient Community Setting In The United States
- Radiofrequency For Treatment of Metastatic Thyroid Cancer
- Radio frequency ablation for metastatic Papillary thyroid cancer